Clinical trial
Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection - a Prospective Observational Cohort Study
NCT04094272 is registered in ClinicalTrials.gov with Kantonsspital Olten as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection - a Prospective Observational Cohort Study
- Lead sponsor
- Kantonsspital Olten
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2017
- Completion date
- June 1, 2019
- Enrollment
- 49 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic hepatitis c, pulmonary artery hypertension